TNG — Transgene SA Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Transgene SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	26.4	49.6	26.8	15.7	16.7
Net Total Accounts Receivable
Net Total Receivables	2.06	11.2	3.59	1.38	2.9
Prepaid Expenses
Total Other Current Assets
Total Current Assets	30.7	62.2	46.5	18	20.7
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	13.1	11.3	11.2	12.3	14.3
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	85.5	102	66.4	45.2	42.2
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	13.6	14.6	12.8	10	14
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	35.2	34.6	28.6	29.6	27
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	50.3	67.2	37.8	15.6	15.2
Total Liabilities & Shareholders' Equity	85.5	102	66.4	45.2	42.2
Total Common Shares Outstanding